{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T05:10:06Z","timestamp":1773983406102,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T00:00:00Z","timestamp":1733961600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","plefa.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.plefa.2024.102663","type":"journal-article","created":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T00:17:14Z","timestamp":1734049034000},"page":"102663","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["The effect of long-chain n-3 PUFA on liver transcriptome in human obesity"],"prefix":"10.1016","volume":"204","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-9250-4427","authenticated-orcid":false,"given":"Rebeka","family":"Joerg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bianca K.","family":"Itariu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melina","family":"Amor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Bilban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Langer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerhard","family":"Prager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6379-7235","authenticated-orcid":false,"given":"Florian","family":"Joerg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas M.","family":"Stulnig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.plefa.2024.102663_bib0001","first-page":"896","article-title":"Metabolic syndrome a widespread threatening condition; risk factors, diagnostic criteria, therapeutic options, prevention and controversies: an overview","volume":"118","author":"Amihaesei","year":"2014","journal-title":"Rev. Med. Chir. Soc. Med. Nat. Iasi."},{"key":"10.1016\/j.plefa.2024.102663_bib0002","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.anndiagpath.2018.09.009","article-title":"Nonalcoholic fatty liver disease (NAFLD): diagnosis, pitfalls, and staging","volume":"37","author":"Koch","year":"2018","journal-title":"Ann. Diagn. Pathol."},{"key":"10.1016\/j.plefa.2024.102663_bib0003","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1136\/bmj.p1587","article-title":"Associations rename fatty liver disease to reduce stigma","volume":"382","author":"Thornton","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.plefa.2024.102663_bib0004","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-024-03095-3","article-title":"A new framework for the diagnosis, staging and management of obesity in adults","author":"Busetto","year":"2024","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.plefa.2024.102663_bib0005","first-page":"691","article-title":"MASLD: a systemic metabolic disorder with cardiovascular and malignant complications","volume":"73","author":"Targher","year":"2024","journal-title":"Gut"},{"issue":"10322","key":"10.1016\/j.plefa.2024.102663_bib0006","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0140-6736(21)01919-X","article-title":"Obesity management as a primary treatment goal for type 2 diabetes: time to reframe the conversation","volume":"399","author":"Lingvay","year":"2022","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.plefa.2024.102663_bib0007","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.3390\/ijms20092358","article-title":"Adipose tissue dysfunction as determinant of obesity-associated metabolic complications","volume":"20","author":"Longo","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.plefa.2024.102663_bib0008","doi-asserted-by":"crossref","first-page":"C375","DOI":"10.1152\/ajpcell.00379.2020","article-title":"Adipose tissue inflammation and metabolic dysfunction in obesity","volume":"320","author":"Kawai","year":"2021","journal-title":"Am. J. Physiol. Cell Physiol"},{"issue":"5","key":"10.1016\/j.plefa.2024.102663_bib0009","doi-asserted-by":"crossref","first-page":"G852","DOI":"10.1152\/ajpgi.00521.2005","article-title":"Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation","volume":"290","author":"Reddy","year":"2006","journal-title":"Am. J. Physiol. Gastrointest. Liver. Physiol."},{"issue":"4","key":"10.1016\/j.plefa.2024.102663_bib0010","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1159\/000539371","article-title":"EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"17","year":"2024","journal-title":"Obes. Facts"},{"key":"10.1016\/j.plefa.2024.102663_bib0011","doi-asserted-by":"crossref","DOI":"10.1152\/physrev.00063.2017","article-title":"Mechanisms of insulin action and insulin resistance","author":"Petersen","year":"2018","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.plefa.2024.102663_bib0012","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1046\/j.1365-2362.32.s3.3.x","article-title":"Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and \u03b2-cell dysfunction","volume":"32","author":"Boden","year":"2002","journal-title":"Eur. J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.plefa.2024.102663_bib0013","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1159\/000212758","article-title":"Obesity, inflammation, and insulin resistance\u2013a mini-review","volume":"55","author":"Zeyda","year":"2009","journal-title":"Gerontology"},{"issue":"9","key":"10.1016\/j.plefa.2024.102663_bib0014","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nrd.2016.75","article-title":"Targeting adipose tissue in the treatment of obesity-associated diabetes","volume":"15","author":"Kusminski","year":"2016","journal-title":"Nat. Rev. Drug Disc"},{"issue":"10","key":"10.1016\/j.plefa.2024.102663_bib0015","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.3390\/nu9101158","article-title":"Fatty acids consumption: the role metabolic aspects involved in obesity and its associated disorders","volume":"9","author":"Silva Figueiredo","year":"2017","journal-title":"Nutrients."},{"issue":"3","key":"10.1016\/j.plefa.2024.102663_bib0016","first-page":"1461","article-title":"Scientific opinion on dietary reference values for fats, including saturated fatty acids, polyunsaturated fatty acids, monounsaturated fatty acids, trans fatty acids, and cholesterol","volume":"8","year":"2010","journal-title":"EFSA J"},{"key":"10.1016\/j.plefa.2024.102663_bib0017","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.freeradbiomed.2019.05.029","article-title":"Lipidomic biomarkers and mechanisms of lipotoxicity in non-alcoholic fatty liver disease","volume":"144","author":"Svegliati-Baroni","year":"2019","journal-title":"Free Radic. Biol. Med"},{"issue":"5","key":"10.1016\/j.plefa.2024.102663_bib0018","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1042\/BST20160474","article-title":"Omega-3 fatty acids and inflammatory processes: from molecules to man","volume":"45","author":"Calder","year":"2017","journal-title":"Biochem. Soc. Trans."},{"issue":"33","key":"10.1016\/j.plefa.2024.102663_bib0019","doi-asserted-by":"crossref","first-page":"23577","DOI":"10.1074\/jbc.274.33.23577","article-title":"Sterol regulatory element binding protein-1 expression is suppressed by dietary polyunsaturated fatty acids: a mechanism for the coordinate suppression of lipogenic genes by polyunsaturated fats","volume":"274","author":"Xu","year":"1999","journal-title":"J. Biolog. Chem"},{"issue":"5","key":"10.1016\/j.plefa.2024.102663_bib0020","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.3945\/ajcn.112.037432","article-title":"Long-chain n-3 PUFAs reduce adipose tissue and systemic inflammation in severely obese nondiabetic patients: a randomized controlled trial","volume":"96","author":"Itariu","year":"2012","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.plefa.2024.102663_bib0021","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.33549\/physiolres.932715","article-title":"The effect of n-3 fatty acids on glucose homeostasis and insulin sensitivity","volume":"63","author":"Flachs","year":"2014","journal-title":"Physiol. Res."},{"issue":"5","key":"10.1016\/j.plefa.2024.102663_bib0022","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/1440-1681.13750","article-title":"Omega-3 polyunsaturated fatty acids in the treatment of non-alcoholic fatty liver disease: an umbrella systematic review and meta-analysis","volume":"50","author":"Musazadeh","year":"2023","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"20","key":"10.1016\/j.plefa.2024.102663_bib0023","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/j.jacc.2011.06.063","article-title":"Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events","volume":"58","author":"Mozaffarian","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.plefa.2024.102663_bib0024","unstructured":"Bioinformatics Graz. CARMAweb 1.6 2016, March [Available from: https:\/\/carmaweb.genome.tugraz.at\/carma\/."},{"key":"10.1016\/j.plefa.2024.102663_bib0025","unstructured":"GSEA. Gene set enrichment analysis (GSEA) user guide (2019). Available from: https:\/\/www.gsea-msigdb.org\/gsea\/doc\/GSEAUserGuideFrame.html."},{"issue":"4","key":"10.1016\/j.plefa.2024.102663_bib0026","doi-asserted-by":"crossref","DOI":"10.3390\/nu11040872","article-title":"Oxidative stress and non-alcoholic fatty liver disease: effects of omega-3 fatty acid supplementation","volume":"11","author":"Yang","year":"2019","journal-title":"Nutrients."},{"issue":"7","key":"10.1016\/j.plefa.2024.102663_bib0027","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.2337\/dc14-3101","article-title":"Effects of dietary n-3 fatty acids on hepatic and peripheral insulin sensitivity in insulin-resistant humans","volume":"38","author":"Lalia","year":"2015","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.plefa.2024.102663_bib0028","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1007\/s10620-020-06117-5","article-title":"Omega-3 Fatty Acids and Gut Microbiota: a Reciprocal Interaction in Nonalcoholic Fatty Liver Disease","volume":"65","author":"Shama","year":"2020","journal-title":"Dig. Dis. Sci."},{"issue":"123","key":"10.1016\/j.plefa.2024.102663_bib0029","doi-asserted-by":"crossref","first-page":"ra41","DOI":"10.1126\/scisignal.2000778","article-title":"Negative feedback in noncanonical NF-kappaB signaling modulates NIK stability through IKKalpha-mediated phosphorylation","volume":"3","author":"Razani","year":"2010","journal-title":"Sci. Signal."},{"key":"10.1016\/j.plefa.2024.102663_bib0030","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1476-511X-12-16","article-title":"Modulating the inflammatory properties of activated microglia with Docosahexaenoic acid and Aspirin","volume":"12","author":"Pettit","year":"2013","journal-title":"Lipids Health Dis."},{"issue":"7","key":"10.1016\/j.plefa.2024.102663_bib0031","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1194\/jlr.M045898","article-title":"Genome-wide association study of the plasma triglyceride response to an n-3 polyunsaturated fatty acid supplementation","volume":"55","author":"Rudkowska","year":"2014","journal-title":"J. Lipid Res."},{"issue":"8","key":"10.1016\/j.plefa.2024.102663_bib0032","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.cmet.2021.06.012","article-title":"FXR activation protects against NAFLD via bile-acid-dependent reductions in lipid absorption","volume":"33","author":"Clifford","year":"2021","journal-title":"Cell Metab."},{"issue":"6","key":"10.1016\/j.plefa.2024.102663_bib0033","doi-asserted-by":"crossref","first-page":"671","DOI":"10.2131\/jts.42.671","article-title":"Fish oil feeding reverses hepatomegaly and disrupted hepatic function due to the lack of FXR signaling","volume":"42","author":"Miyata","year":"2017","journal-title":"J. Toxicol. Sci."},{"issue":"4","key":"10.1016\/j.plefa.2024.102663_bib0034","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0952-3278(98)90038-2","article-title":"Effect of dietary n-3 fatty acids on interleukin-2 and interleukin-2 receptor alpha expression in activated murine lymphocytes","volume":"58","author":"Jolly","year":"1998","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"issue":"1","key":"10.1016\/j.plefa.2024.102663_bib0035","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1186\/s13104-019-4540-5","article-title":"Effect of curcumin supplementation on serum expression of select cytokines and chemokines in a female rat model of nonalcoholic steatohepatitis","volume":"12","author":"Pickich","year":"2019","journal-title":"BMC. Res. Notes."},{"issue":"8","key":"10.1016\/j.plefa.2024.102663_bib0036","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1017\/S0007114511001541","article-title":"Gene-PUFA interactions and obesity risk","volume":"106","author":"Jourdan","year":"2011","journal-title":"Br. J. Nutr."},{"issue":"6227","key":"10.1016\/j.plefa.2024.102663_bib0037","first-page":"1260","article-title":"Interleukin-3 amplifies acute inflammation and is a potential therapeutic target in sepsis","volume":"347","author":"Weber","year":"2015","journal-title":"Science (1979)"},{"issue":"2","key":"10.1016\/j.plefa.2024.102663_bib0038","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/apha.12427","article-title":"The neuropeptide vasoactive intestinal peptide: direct effects on immune cells and involvement in inflammatory and autoimmune diseases","volume":"213","author":"Ganea","year":"2015","journal-title":"Acta Physiol. (Oxf)"},{"issue":"30","key":"10.1016\/j.plefa.2024.102663_bib0039","doi-asserted-by":"crossref","first-page":"27728","DOI":"10.1074\/jbc.M411657200","article-title":"Simultaneous blockade of NFkappaB, JNK, and p38 MAPK by a kinase-inactive mutant of the protein kinase TAK1 sensitizes cells to apoptosis and affects a distinct spectrum of tumor necrosis factor [corrected] target genes","volume":"280","author":"Thiefes","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.plefa.2024.102663_bib0040","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s11892-018-1053-x","article-title":"Genetics of severe obesity","volume":"18","author":"Fairbrother","year":"2018","journal-title":"Curr. Diab. Rep."},{"issue":"5","key":"10.1016\/j.plefa.2024.102663_bib0041","doi-asserted-by":"crossref","DOI":"10.3390\/nu11050945","article-title":"Protective effects of omega-3 fatty acids in cancer-related complications","volume":"11","author":"Freitas","year":"2019","journal-title":"Nutrients."}],"container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952327824000577?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952327824000577?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T07:43:59Z","timestamp":1741592639000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952327824000577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":41,"alternative-id":["S0952327824000577"],"URL":"https:\/\/doi.org\/10.1016\/j.plefa.2024.102663","relation":{},"ISSN":["0952-3278"],"issn-type":[{"value":"0952-3278","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of long-chain n-3 PUFA on liver transcriptome in human obesity","name":"articletitle","label":"Article Title"},{"value":"Prostaglandins, Leukotrienes and Essential Fatty Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.plefa.2024.102663","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102663"}}